Innate Immunity: PRRs (TLRs, NLRP3), IL-1β, Pyroptosis, and Complement Pathways — Case Context with West Nile Virus

Pattern Recognition Receptors (PRRs) and Early Innate Sensing

  • There are two main pattern recognition receptor (PRR) families discussed here that recognize RNA vs DNA in endosomes:

    • TLRs recognizing viral nucleic acids in endosomes:
    • TLR3 recognizes double-stranded RNA (dsRNA).
    • TLR7 and TLR8 recognize single-stranded RNA (ssRNA).
    • TLR9 recognizes unmethylated DNA (CpG DNA).
    • These receptors trigger innate immune signaling that leads to antiviral states in cells and systemic inflammation when signals come from the bloodstream or lymph.

  • Key distinction noted in the lecture:

    • TLR signaling to interferon and inflammatory responses differs among the receptors:
    • TLR3 (dsRNA) uses a TRIF-dependent pathway that prominently engages IRF3.
    • TLR7/8/9 use MyD88-dependent pathways that engage IRF7 and NF-κB, leading to interferon-β (IFN-β) production and downstream ISG (interferon-stimulated gene) activation.
    • The end result across these TLRs is an antiviral state via IFN-β signaling to neighboring cells, but the intermediate signaling routes differ (IRF3 vs IRF7, and NF-κB involvement).

  • Receptors and outcomes in general:

    • Endosomal recognition of viral nucleic acids leads to transcription factor activation and gene expression changes (e.g., IFN-β, ISGs).
    • The signaling culminates in antiviral states and inflammation, with the specific transcription factors guiding the exact set of responses.

Toll-like Receptors (TLRs) in Endosomes: Ligands and Outcomes

  • Ligands and receptors discussed:

    • TLR3 — ligand: dsRNA; pathway: TRIF → IRF3; outcome: interferon production and inflammatory gene expression.
    • TLR7/8 — ligands: ssRNA; pathway: MyD88 → IRF7 and NF-κB; outcome: IFN-β production and inflammatory responses.
    • TLR9 — ligand: unmethylated CpG DNA; pathway: MyD88 → IRF7 and NF-κB; outcome: IFN-β production and inflammatory responses.

  • The speaker notes that all three receptors (7, 8, 9) typically signal toward producing IFN-β and establishing an antiviral state, whereas TLR3 has a slightly different intermediate signaling but similar endpoint.

  • Summary of signaling progression for TLRs:

    • Ligand binding in endosome → recruitment of adaptors (TRIF for TLR3; MyD88 for TLR7/8/9) → activation of transcription factors (IRF3 for TLR3; IRF7 and NF-κB for TLR7/8/9) → production of IFN-β → signaling to neighboring cells to induce ISGs and antiviral state.

Interferon Response and ISGs

  • Interferon-β (IFN-β) is produced downstream of TLR signaling (via IRFs) and acts to induce interferon-stimulated genes (ISGs).
  • ISGs establish antiviral states in neighboring cells, helping to limit viral replication and spread.
  • The lecture emphasizes that the steps to antiviral state are similar across the TLR pathways that lead to IFN-β production (IRF3/IRF7 dependent) and ISG induction.

NLRP3 Inflammasome and IL-1β Maturation

  • The NLRP3 inflammasome is a distinct PRR complex that does not activate a transcription factor in the same way as TLR signaling.

  • Components and assembly:

    • Receptor: NLRP3 (a sensor)
    • Adaptor: ASC (apoptosis-associated speck-like protein containing a CARD)
    • Protease: procaspase-1 (which is activated within the inflammasome to caspase-1)
    • The inflammasome complex oligomerizes to form the active inflammasome particle.

  • Function:

    • Caspase-1 (activated within the inflammasome) cleaves pro-IL-1β to mature IL-1β (and pro-IL-18 to IL-18).
    • IL-1β is a potent pro-inflammatory cytokine; IL-1α is also present but is not the focus in this class (the lecturer suggested ignoring IL-1α for this course).

  • Pyroptosis and IL-1β release:

    • The inflammasome triggers pyroptosis, a form of inflammatory programmed cell death, to release IL-1β and other inflammatory signals into the extracellular space.
    • Pyroptosis is described as inflammatory cell death; its execution involves pore formation in the plasma membrane.

  • Gasdermin D (GSDMD) and pore formation:

    • Caspase-1 (canonical pyroptosis) cleaves gasdermin D to form pores in the cell membrane, enabling IL-1β release.
    • In the slide, the speaker refers to caspase-4 cleaving gasdermin D in the context of noncanonical pyroptosis (this is a nuance: canonical pyroptosis is caspase-1; noncanonical involves caspase-4/5 in humans).

  • Significance:

    • The inflammasome-mediated maturation and release of IL-1β amplify inflammation and recruit/activate other immune cells.
    • This pathway represents a non-transcriptional route to inflammation and cytokine release, distinct from the NF-κB/IRF-mediated TLR pathways.

  • Important clarifications from the lecture:

    • IL-1β is the key pro-inflammatory cytokine produced after inflammasome activation; IL-1α is not the primary focus here.
    • The targeted cytokine release (IL-1β) requires the inflammasome to process the latent pro-IL-1β into its active form, which is then secreted after pyroptosis or through other secretion mechanisms.

Inflammasome Signaling and the “Different” Pathway

  • The inflammasome pathway is different from the classic transcription-factor–driven innate pathways because it acts at the level of protease activation and cytokine maturation rather than primarily by gene transcription.
  • The slide emphasizes that this pathway culminates in the production and release of proinflammatory cytokines (like IL-1β) rather than just signaling through transcription factors to produce antiviral genes.

Summary: TLRs and Inflammasome Together

  • TLRs (endosomal) detect viral RNA or DNA and drive transcriptional programs leading to IFN-β and ISGs, plus inflammatory cytokines via NF-κB.
  • The NLRP3 inflammasome drives maturation of IL-1β and pyroptotic cell death, releasing IL-1β and amplifying inflammation without relying on transcriptional amplification in the moment.
  • The two pathways can operate in parallel during infection, contributing to distinct but complementary arms of innate immunity.

Endosome TLRs and Ligand Specificity (Revisit for Exam Context)

  • The lecture revisits common signals in this course: endosomal TLRs recognize viral nucleic acids and signal to induce interferon responses and inflammatory mediators.
  • Ligand specifics recap:
    • TLR3: dsRNA
    • TLR7/8: ssRNA
    • TLR9: unmethylated DNA
  • The discussion also highlights that signaling outcomes differ slightly by receptor but converge on antiviral states or inflammation as appropriate.

Extracellular vs. Intracellular Sensing and the Role of Complement

  • The immune response begins in the bloodstream or lymph, where innate immune recognition can trigger both antimicrobial responses and inflammation.
  • Complement system considerations mentioned in the lecture include:
    • There are three pathways to activate complement: classical, lectin, and alternative.
    • The speaker focuses on the alternative pathway in many viral contexts (especially when no antibodies are present), noting that C3b binding to membranes and regulation by host proteins determines activation.
    • Classical pathway requires antibody involvement (antigen–antibody complexes) to activate via C1q; lectin pathway involves Mannose-binding lectin (MBL) binding to carbohydrates on pathogens.
  • The sequence and key components often described:
    • C3 spontaneously hydrolyzes in plasma to C3(H2O); properdin and other factors influence the outcome.
    • C3 convertases:
    • Alternative pathway: C3bBb
    • Classical/lectin pathways: C4b2a
    • C5 convertases:
    • Classical/lectin: C4b2a3b
    • Alternative: C3bBb3b
    • Effector outcomes:
    • Opsonization: C3b (promotes phagocytosis)
    • Anaphylatoxins: C3a and C5a (promote inflammation and recruit immune cells)
    • Membrane attack complex (MAC): C5b-9 (direct lysis of susceptible pathogens)
  • The lecture notes that bradykinin and kinins contribute to vascular permeability and inflammation in tissue; bradykinin is particularly active in tissue rather than the bloodstream.
  • Regulators such as DAF (CD55), MCP (CD46), factor H, and factor I prevent excessive complement activation on host cells; decay-accelerating factor (DAF) and MCP help prevent C3b from driving unchecked activation on host tissues.
  • Pentraxins (e.g., CRP, PTX3) are serum proteins that can bind microbes and promote uptake via receptors, thereby acting as a bridge to the complement system and enhancing opsonization.
  • Antimicrobial peptides are part of the innate response and may be present at sites of infection, particularly mucosal surfaces; they provide an additional antimicrobial layer alongside complement and phagocytosis.

Antimicrobial Defenses Beyond Cells: Pentraxins to Peptides

  • Pentraxins (CRP, PTX3) promote recognition and uptake of microbes by binding to their surfaces and interacting with Fc receptors or complement components.
  • Antimicrobial peptides (AMPs) are part of the innate defense and can be produced by epithelial and immune cells to directly neutralize pathogens.
  • The lecture notes that AMPs are more likely to be abundant at mucosal surfaces than in the bloodstream, contributing to local defense.
  • The question-and-answer portion touches on the potential roles of AMPs and pentraxins in endocytosis and pathogen uptake, highlighting their contribution to early innate responses.

Scavenger Receptors and Phagocytosis

  • Scavenger receptors mediate phagocytosis by binding to a wide range of ligands, including foreign microbes and dead/dying self cells.
  • These receptors are often involved in recognizing “non-self” or altered-self patterns and promoting the uptake and clearance of pathogens or debris.
  • The discussion notes that scavenger receptors largely mediate phagocytosis and can assist in clearance of apoptotic cells and microbial particles.

Mucosal Immunity and Lymphoid Structures

  • The lecture outlines how mucosal immunity relates to lymph node-like structures near mucosal surfaces:
    • M cells transcytose antigens from luminal spaces to underlying immune tissues.
    • Antigens deliver to subepithelial compartments where dendritic cells, T cells, and B cells interact.
    • Germinal center formation and T/B cell activation occur, leading to adaptive responses even at mucosal sites.
  • When infection is in peripheral tissue (e.g., an arm), antigen and pathogen drainage to the nearest lymph node (often in the armpit) initiates germinal center reactions and adaptive responses.
  • The notes emphasize that mucosal sites can exhibit immune activation locally, with downstream lymph node–like organizations coordinating the response.

Integrated Immune Response: West Nile Virus Immune Scenario (Instructor’s Case)

  • Scenario setup discussed in class: a mosquito bite transmits (enveloped) West Nile virus into the bloodstream.
  • Early recognition:
    • Pattern recognition receptors (PRRs) in blood cells or endothelial/epithelial cells detect the virus in endosomes or after endocytosis.
    • This triggers an innate response including IFN-β production and ISG induction, establishing an antiviral state.
  • Complement and enveloped vs nonenveloped distinction:
    • Enveloped viruses present membranes that allow complement components to interact more readily with viral envelopes, promoting activation (classical/alternative/lectin can contribute depending on context).
    • If the virus were nonenveloped, complement could still be activated, but the specifics of this slide highlight enveloped viruses as a context for complement engagement; the lecturer notes that if the virus were nonenveloped, certain complement pathways might not be activated in the same way via membrane-associated steps.
  • Complement pathway choices and outcomes in the scenario:
    • Alternative pathway commonly contributes when antibodies are not yet present.
    • C3 spontaneously hydrolyzes to form C3b that binds to microbial membranes; this can drive formation of C3 convertases (C3bBb) and downstream cascades.
    • Classical pathway would require antibodies (antigen–antibody complexes) to form C1q triggers; lectin pathway involves MBL binding to surface carbohydrates and activating MASP-2 to cleave C4 and C2.
  • Key effector outcomes of complement relevant to the scenario:
    • Opsonization: C3b coats the virus to enhance phagocytosis.
    • Inflammation: C3a and C5a promote recruitment and activation of immune cells.
    • Lysis: MAC (C5b-9) can lyse susceptible virions or infected cells.
  • Interplay with inflammatory mediators:
    • Bradykinin (kinins) contributes to vascular permeability and inflammation, enabling immune components to access infected tissues.
    • Inflammation and complement activation can occur in parallel, but leukocyte recruitment and vascular leakage often precede or accompany complement effects to deliver immune components to the site of infection.
  • Adaptive bridging and tissue context:
    • Dendritic cells capture antigens at mucosal surfaces or in tissues and migrate to lymphoid tissues to prime T and B cells, forming germinal centers and supporting adaptive immunity.
    • In the arm (peripheral tissue), the pathogen is drained to local lymph nodes to initiate adaptive responses, including T cell activation and germinal center formation.
  • Practical takeaway:
    • The innate arm provides rapid defense and paves the way for adaptive immunity. The virus-specificity and timing determine how complement, PRRs, and antimicrobial peptides contribute to clearance.

Exam and Review Notes: Key Takeaways and Connections

  • TLRs in endosomes (3, 7, 8, 9):
    • 3 recognizes dsRNA; signals via TRIF to IRF3; leads to antiviral state.
    • 7/8/9 recognize ssRNA or unmethylated DNA; signals via MyD88 to IRF7 and NF-κB; lead to IFN-β and inflammation.
    • Outcome convergence: IFN-β production and ISG induction, with pathogen-specific transcriptional programs.
  • NLRP3 inflammasome: canonical activation leads to IL-1β maturation via caspase-1, pyroptotic cell death via pore-forming gasdermin D, and strong inflammatory responses.
  • IL-1β is a central pro-inflammatory cytokine in inflammasome-driven responses; IL-1α is present but not the focus in this section.
  • Complement overview: three activation pathways (classical, lectin, alternative) converge on C3 activation and downstream effector functions (opsonization, inflammation, lysis).
    • Key components and forms:
    • C3 convertases:
      • Alternative: C3bBb
      • Classical/lectin: C4b2a
    • C5 convertases:
      • Classical/lectin: C4b2a3b
      • Alternative: C3bBb3b
    • MAC: C5b-9
    • Primary effector outputs:
    • Opsonization: C3b
    • Inflammation: C3a, C5a
    • Lysis: MAC
    • Regulation by host proteins (DAF, MCP, CD55, CD46, factor H, factor I) prevents inappropriate activation on host tissues.
  • Pentraxins and antimicrobial peptides are important soluble mediators in innate defense:
    • Pentraxins (CRP, PTX3) promote opsonization and uptake and can interact with complement.
    • Antimicrobial peptides provide direct antimicrobial activity, especially at mucosal surfaces.
  • Scavenger receptors contribute to phagocytosis by recognizing foreign materials and altered self, aiding clearance of pathogens and dead/dying cells.
  • Mucosal immunity and lymphoid organization:
    • M cells transport antigens to underlying immune tissue, enabling dendritic cells and lymphocytes to sample, activate, and form germinal centers locally.
    • Tissue-level responses coordinate with draining lymph nodes to initiate adaptive immunity.
  • Practical exam context from the lecture:
    • Expect questions on how TLR signaling leads to IFN-β and ISGs, how inflammasomes activate IL-1β, and how complement pathways contribute to defense against enveloped viruses.
    • The instructor notes that there may be a specific slide about TLRs signaling to interferon and differences among TLR3 vs TLR7/8/9 in signaling, with emphasis on the antiviral state outcomes.
  • Connections to foundational principles:
    • Innate immune recognition (PRRs) shapes immediate responses and sets the stage for adaptive immunity.
    • The balance between inflammation and regulation is critical to control tissue damage while clearing infection.
    • The interplay between endosomal sensing (TLRs), cytosolic sensing (inflammasomes), and humoral components (complement, pentraxins) provides multiple layers of defense, with distinct regulatory checkpoints.

Quick Reference: Key Formulas and Notations (LaTeX)

  • C3 split:
    C3→C3a+C3b\mathrm{C3} \rightarrow \mathrm{C3a} + \mathrm{C3b}
  • C5 split:
    C5→C5a+C5b\mathrm{C5} \rightarrow \mathrm{C5a} + \mathrm{C5b}
  • Classical/lectin C3 convertase:
    C4b2a\text{C4b2a}
  • Alternative C3 convertase:
    C3bBb\text{C3bBb}
  • Classical/lectin C5 convertase:
    C4b2a3b\text{C4b2a3b}
  • Alternative C5 convertase:
    C3bBb3b\text{C3bBb3b}
  • Membrane attack complex (MAC):
    C5b-9\text{C5b-9}
  • Receptor–adaptor signaling routes (illustrative):
    • TLR3: \text{TRIF} \rightarrow \text{IRF3}
    • TLR7/8/9: \text{MyD88} \rightarrow \text{IRF7, NF-κB}
  • Inflammasome maturation: pro-IL-1β \rightarrow IL-1β via caspase-1; pyroptosis via gasdermin D (GSDMD) pores